151 related articles for article (PubMed ID: 31254065)
1. Volumetric assessment of glioblastoma and its predictive value for survival.
Henker C; Hiepel MC; Kriesen T; Scherer M; Glass Ä; Herold-Mende C; Bendszus M; Langner S; Weber MA; Schneider B; Unterberg A; Piek J
Acta Neurochir (Wien); 2019 Aug; 161(8):1723-1732. PubMed ID: 31254065
[TBL] [Abstract][Full Text] [Related]
2. Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival.
Henker C; Kriesen T; Glass Ä; Schneider B; Piek J
J Neurooncol; 2017 Nov; 135(2):391-402. PubMed ID: 28755324
[TBL] [Abstract][Full Text] [Related]
3. Association Between Tumor Compartment Volumes, the Incidence of Pretreatment Seizures, and Statin-Mediated Protective Effects in Glioblastoma.
Henker C; Kriesen T; Scherer M; Glass Ä; von Deimling A; Bendszus M; Weber MA; Herold-Mende C; Unterberg A; Piek J
Neurosurgery; 2019 Oct; 85(4):E722-E729. PubMed ID: 30888031
[TBL] [Abstract][Full Text] [Related]
4. Quantitative volumetric assessment of baseline enhancing tumor volume as an imaging biomarker predicts overall survival in patients with glioblastoma.
Auer TA; Della Seta M; Collettini F; Chapiro J; Zschaeck S; Ghadjar P; Badakhshi H; Florange J; Hamm B; Budach V; Kaul D
Acta Radiol; 2021 Sep; 62(9):1200-1207. PubMed ID: 32938221
[TBL] [Abstract][Full Text] [Related]
5. Reliability of Semi-Automated Segmentations in Glioblastoma.
Huber T; Alber G; Bette S; Boeckh-Behrens T; Gempt J; Ringel F; Alberts E; Zimmer C; Bauer JS
Clin Neuroradiol; 2017 Jun; 27(2):153-161. PubMed ID: 26490369
[TBL] [Abstract][Full Text] [Related]
6. Effect of 10 different polymorphisms on preoperative volumetric characteristics of glioblastoma multiforme.
Henker C; Kriesen T; Fürst K; Goody D; Glass Ä; Pützer BM; Piek J
J Neurooncol; 2016 Feb; 126(3):585-92. PubMed ID: 26603163
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study.
Pérez-Beteta J; Martínez-González A; Molina D; Amo-Salas M; Luque B; Arregui E; Calvo M; Borrás JM; López C; Claramonte M; Barcia JA; Iglesias L; Avecillas J; Albillo D; Navarro M; Villanueva JM; Paniagua JC; Martino J; Velásquez C; Asenjo B; Benavides M; Herruzo I; Delgado MD; Del Valle A; Falkov A; Schucht P; Arana E; Pérez-Romasanta L; Pérez-García VM
Eur Radiol; 2017 Mar; 27(3):1096-1104. PubMed ID: 27329522
[TBL] [Abstract][Full Text] [Related]
8. Deep learning for glioblastoma segmentation using preoperative magnetic resonance imaging identifies volumetric features associated with survival.
Wan Y; Rahmat R; Price SJ
Acta Neurochir (Wien); 2020 Dec; 162(12):3067-3080. PubMed ID: 32662042
[TBL] [Abstract][Full Text] [Related]
9. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
[TBL] [Abstract][Full Text] [Related]
10. Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study.
Czarnek N; Clark K; Peters KB; Mazurowski MA
J Neurooncol; 2017 Mar; 132(1):55-62. PubMed ID: 28074320
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival.
Grossman R; Shimony N; Shir D; Gonen T; Sitt R; Kimchi TJ; Harosh CB; Ram Z
Ann Surg Oncol; 2017 Mar; 24(3):794-800. PubMed ID: 27766560
[TBL] [Abstract][Full Text] [Related]
12. Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images.
Naeini KM; Pope WB; Cloughesy TF; Harris RJ; Lai A; Eskin A; Chowdhury R; Phillips HS; Nghiemphu PL; Behbahanian Y; Ellingson BM
Neuro Oncol; 2013 May; 15(5):626-34. PubMed ID: 23444259
[TBL] [Abstract][Full Text] [Related]
13. Restriction Spectrum Imaging Improves Risk Stratification in Patients with Glioblastoma.
Krishnan AP; Karunamuni R; Leyden KM; Seibert TM; Delfanti RL; Kuperman JM; Bartsch H; Elbe P; Srikant A; Dale AM; Kesari S; Piccioni DE; Hattangadi-Gluth JA; Farid N; McDonald CR; White NS
AJNR Am J Neuroradiol; 2017 May; 38(5):882-889. PubMed ID: 28279985
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686.
Boxerman JL; Zhang Z; Safriel Y; Rogg JM; Wolf RL; Mohan S; Marques H; Sorensen AG; Gilbert MR; Barboriak DP
Neuro Oncol; 2018 Sep; 20(10):1400-1410. PubMed ID: 29590461
[TBL] [Abstract][Full Text] [Related]
15. The incidence and significance of multicentric noncontrast-enhancing lesions distant from a histologically-proven glioblastoma.
Lasocki A; Gaillard F; Tacey MA; Drummond KJ; Stuckey SL
J Neurooncol; 2016 Sep; 129(3):471-478. PubMed ID: 27412000
[TBL] [Abstract][Full Text] [Related]
16. Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.
Duma CM; Kim BS; Chen PV; Plunkett ME; Mackintosh R; Mathews MS; Casserly RM; Mendez GA; Furman DJ; Smith G; Oh N; Caraway CA; Sanathara AR; Dillman RO; Riley AS; Weiland D; Stemler L; Cannell R; Abrams DA; Smith A; Owen CM; Eisenberg B; Brant-Zawadzki M
J Neurosurg; 2016 Dec; 125(Suppl 1):40-49. PubMed ID: 27903197
[TBL] [Abstract][Full Text] [Related]
17. Multiparameter MRI Predictors of Long-Term Survival in Glioblastoma Multiforme.
Stringfield O; Arrington JA; Johnston SK; Rognin NG; Peeri NC; Balagurunathan Y; Jackson PR; Clark-Swanson KR; Swanson KR; Egan KM; Gatenby RA; Raghunand N
Tomography; 2019 Mar; 5(1):135-144. PubMed ID: 30854451
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutations associated with MRI-derived volumetric features in glioblastoma.
Gutman DA; Dunn WD; Grossmann P; Cooper LA; Holder CA; Ligon KL; Alexander BM; Aerts HJ
Neuroradiology; 2015 Dec; 57(12):1227-37. PubMed ID: 26337765
[TBL] [Abstract][Full Text] [Related]
19. FLAIRectomy in Supramarginal Resection of Glioblastoma Correlates With Clinical Outcome and Survival Analysis: A Prospective, Single Institution, Case Series.
Certo F; Altieri R; Maione M; Schonauer C; Sortino G; Fiumanò G; Tirrò E; Massimino M; Broggi G; Vigneri P; Magro G; Visocchi M; Barbagallo GMV
Oper Neurosurg (Hagerstown); 2021 Jan; 20(2):151-163. PubMed ID: 33035343
[TBL] [Abstract][Full Text] [Related]
20. Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma.
Burth S; Kickingereder P; Eidel O; Tichy D; Bonekamp D; Weberling L; Wick A; Löw S; Hertenstein A; Nowosielski M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
Neuro Oncol; 2016 Dec; 18(12):1673-1679. PubMed ID: 27298312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
